Studying Malnutrition And Sarcopenia In Older Adults With Acute Myeloid Leukemia

Investigating The Prognostic Significance Of Malnutrition And Sarcopenia In Older Adults With Acute Myeloid Leukemia

This study will explore how malnutrition (poor nutrition/diet) and sarcopenia (a condition that causes a loss of muscle and bone mass) affects study participants over the age of 60 with acute myeloid leukemia (AML) who will receive induction chemotherapy (chemotherapy given as the first treatment to help cancer go into remission) and/or cancer drugs as part of standard care for AML. By studying how these nutritional and skeletal factors, doctors leading this study hope to learn how malnutrition and sarcopenia may be able to predict certain outcomes --such as how long study participants with poor nutrition and muscle loss can live after chemotherapy- for older (age 60+) individuals with AML.

Inclusion Criteria:

• Older Adult patients (greater than or equal to 60 years of age)
• New diagnosis of acute myeloid leukemia (AML)
• Receiving induction therapy (intensive or low intensity therapy)
• Willing and able to provide written informed consent

Exclusion Criteria:

• Presence of a pacemaker or defibrillator.
• Participants who are pregnant at the time of enrollment.
• Anyone unable/unwilling to follow protocol requirements